Physician profile
Dawn E Laprade
NPI 1649526153
$496.43
in general payments reported to CMS, 2019-2025
7 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.53 · 2023: $109 · 2024: $134 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $115.30 | 2022-2025 | Spravato, Invega |
| Alkermes, INC. | $113.20 | 2023-2025 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $77.42 | 2024-2025 | Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $54.80 | 2023-2024 | Abilify Asimtufii, Abilify Maintena |
| Hologic Sales and Service, LLC | $51.28 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Indivior INC. | $44.70 | 2022-2023 | Perseris |
| Vanda Pharmaceuticals INC. | $39.73 | 2022-2024 | Fanapt, Hetlioz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Laprade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.